ARDX stock forecast
Our latest prediction for Ardelyx Inc's stock price was made on the Feb. 23, 2024 when the stock price was at 8.68$.
In the short term (2weeks), ARDX's stock price should underperform the market by -1.95%. During that period the price should oscillate between -20.59% and +15.65%.
In the medium term (3months), ARDX's stock price should underperform the market by -7.02%. During that period the price should oscillate between -56.57% and +34.41%.
Get email alertsCreate a solid portfolio with ARDX
About Ardelyx Inc
ardelyx is focused on enhancing the way people with renal diseases are treated by developing first-in-class medicines. ardelyx's renal pipeline includes the phase 3 development of tenapanor for the treatment of hyperphosphatemia in people with end-stage renal disease who are on dialysis and rdx013, a potassium secretagogue program for the potential treatment of high potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease. in addition, ardelyx has completed phase 3 development of tenapanor for the treatment of irritable bowel syndrome with constipation and anticipates submitting a new drug application to the u.s. food and drug administration for this indication in the second half of 2018. to efficiently bring its treatments to market, ardelyx is pursing strategic collaborations in the u.s. and other countries, including through established agreements with kyowa hakko kirin in japan, fosun pharma in china and knight therapeutics in canada.
At the moment the company generates 17M USD in revenues.
On its last earning announcement, the company reported a loss of -0.30$ per share.
The book value per share is 2.63$
Three months stock forecastFeb. 23, 2024
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
17M | - | -63M | - | -66M | -0.30 | - | - | 232M | 2.63 | - | - | - |